Lyell Immunopharma (LYEL) EBT Margin (QoQ) (2020 - 2026)
Lyell Immunopharma (LYEL) EBT Margin (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Lyell Immunopharma |
295.11 Mn |
295.11 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-2.06 Mn |
| Dec 31, 2025 |
-185.62 Mn |
| Sep 30, 2025 |
32.17 Mn |
| Jun 30, 2025 |
21.61 Mn |
| Mar 31, 2025 |
101.95 Mn |
| Dec 31, 2024 |
-165.29 Mn |
| Sep 30, 2024 |
21.64 Mn |
| Jun 30, 2024 |
127.78 Mn |
| Mar 31, 2024 |
-122.19 Mn |
| Dec 31, 2023 |
-19.35 Mn |
| Sep 30, 2023 |
1.49 Mn |
| Jun 30, 2023 |
-13.53 Mn |
| Mar 31, 2023 |
-8.93 Mn |
| Dec 31, 2022 |
213.95 Mn |
| Sep 30, 2022 |
-213.94 Mn |
| Jun 30, 2022 |
1.22 Mn |
| Mar 31, 2022 |
-1.07 Mn |
| Dec 31, 2021 |
10,152.00 |
| Sep 30, 2021 |
60,319.00 |
| Jun 30, 2021 |
-12,767.00 |
